CHP Merger Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses with a focus on the healthcare or healthcare related industries in the United States. The company was incorporated in 2019 and is based in Summit, New Jersey.
IPO Year: 2020
Exchange: NASDAQ
Website: concordhp.com/chp-merger-corp
PALM BEACH GARDENS, Fla. and SUMMIT, N.J., April 15, 2022 (GLOBE NEWSWIRE) -- Integrity Implants Inc. d/b/a Accelus ("Accelus"), a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, and CHP Merger Corp. ("CHP") (NASDAQ:CHPM, CHPMU and CHPMW))), a special purpose acquisition company (SPAC), announced today that the companies have mutually agreed to terminate, effective immediately, the previously announced business combination agreement dated November 14, 2021 as a result of market conditions. "In light of market conditions, we believe that this strategic pivot will best enable our team to exe
SUMMIT, N.J., Nov. 24, 2021 /PRNewswire/ -- CHP Merger Corp. (the "Company") (NASDAQ:CHPM) today announced that it held a special meeting of stockholders (the "Special Meeting") relating to the proposal (the "Extension Proposal") to amend the Company's amended and restated certificate of incorporation to extend the date by which the Company must complete its initial business combination with Integrity Implants Inc. d/b/a Accelus ("Accelus"), a U.S. based medical technology company focused on the spinal surgery market (the "Accelus Business Combination") from November 26, 2021 to May 26, 2022 (the "Extension"), which the stockholders voted to approve. The Extension Proposal is described in fu
SUMMIT, N.J., Nov. 22, 2021 /PRNewswire/ -- CHP Merger Corp. (the "Company") (NASDAQ:CHPM) today announced that it convened and then adjourned, without conducting any other business, the Company's special meeting of stockholders (the "Special Meeting") held on November 22, 2021. The Special Meeting has been adjourned until November 24, 2021 at 9:00 a.m. Eastern Time (the "Adjournment"). The Special Meeting is being held to vote on the proposal to extend the date by which the Company must consummate the previously announced business combination with Integrity Implants Inc. d/b/a Accelus ("Accelus"), a U.S.-based medical technology company focused on the spinal surgery market (the "Accelus Bus
SUMMIT, N.J., Nov. 22, 2021 /PRNewswire/ -- CHP Merger Corp. (the "Company") (NASDAQ:CHPM) today announced that it will allow those holders of shares of the Company's Class A common stock originally sold as part of the units issued in its initial public offering that elected by 5:00 p.m. Eastern Time on November 18, 2021 to redeem their Class A common stock ("Redeeming Shareholders") in connection with the upcoming special meeting of stockholders on November 24, 2021 (the "Special Meeting"), where stockholders of the Company will vote on whether to amend the Company's amended and restated certificate of incorporation to extend the date by which the Company must complete its initial business
Transaction expected to combine Accelus and CHP Merger Corp., a leading healthcare-focused SPAC.The pro-forma enterprise value of the business combination would be approximately $482 million.Chris Walsh, Accelus CEO and Co-Founder, will become CEO of the combined company, Accelus. Mr. Walsh has 25 years of experience at leading spinal health companies, including Stryker and NuVasive.Joseph Swedish, Chairman of CHP Merger Corp., and seasoned industry executive Alex Lukianov will join the Board of Directors of the combined company. Mr. Swedish has decades of healthcare industry experience having served in positions at Anthem, Trinity Health, Centura and HCA Healthcare. Mr. Lukianov has over 35
SUMMIT, N.J., May 28, 2021 /PRNewswire/ -- As previously announced on May 21, 2021, CHP Merger Corp. (NASDAQ:CHPM) (the "Company") has determined to restate its 2019 and 2020 financial statements (the "Non-Reliance Periods") in light of the U.S. Securities and Exchange Commission's (the "SEC") recently issued "Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies ("SPACs")" (the "Staff Statement"). This Staff Statement issued on April 12, 2021 informed market participants that warrants issued by SPACs and former SPACs may need to be reclassified as liabilities with non-cash fair value adjustments recorded in earnings at each r
4 - CHP Merger Corp. (0001785041) (Issuer)
3 - CHP Merger Corp. (0001785041) (Issuer)
SC 13G/A - CHP Merger Corp. (0001785041) (Subject)
SC 13G/A - CHP Merger Corp. (0001785041) (Subject)
SC 13G/A - CHP Merger Corp. (0001785041) (Subject)
SC 13G - CHP Merger Corp. (0001785041) (Subject)
SC 13G/A - CHP Merger Corp. (0001785041) (Subject)
SC 13G/A - CHP Merger Corp. (0001785041) (Subject)
SC 13G/A - CHP Merger Corp. (0001785041) (Subject)
SC 13G/A - CHP Merger Corp. (0001785041) (Subject)
SC 13G - CHP Merger Corp. (0001785041) (Subject)
SC 13G - CHP Merger Corp. (0001785041) (Subject)
15-12B - CHP Merger Corp. (0001785041) (Filer)
RW - CHP Merger Corp. (0001785041) (Filer)
25-NSE - CHP Merger Corp. (0001785041) (Subject)
25-NSE - CHP Merger Corp. (0001785041) (Subject)
25-NSE - CHP Merger Corp. (0001785041) (Subject)
8-K - CHP Merger Corp. (0001785041) (Filer)
8-K - CHP Merger Corp. (0001785041) (Filer)
10-K - CHP Merger Corp. (0001785041) (Filer)
425 - CHP Merger Corp. (0001785041) (Subject)
8-K - CHP Merger Corp. (0001785041) (Filer)